CATEGORIES

Press Release

LATEST

TRENDING

EDITORS CHOICE

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained

52 physicians from across the U.S. selected for the inaugural cohort of the five-year, $100 million initiative Initiative is part of the BMS Foundation commitment...

New Data Shows No Evidence of COVID-19 Spread in Gyms

Of More than 49.4 Million Health Club Visits, Only 0.0023 Percent Tested Positive for COVID-19

New CRISPR-Based Test for COVID-19 Uses a Smartphone Camera

Imagine swabbing your nostrils, putting the swab in a device, and getting a read-out on your phone in 15 to 30 minutes that tells you if you are infected with the COVID-19 virus